Search Results (1 to 2 of 2 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Cancer
- 1 JMIR Formative Research
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
For example, based on a recent systematic review, most publications use a PSA of greater than 0.4 ng/m L [25] while the RTOG-ASTRO (Radiation Therapy Oncology Group–American Society for Therapeutic Radiology and Oncology) Phoenix Consensus Conference uses a definition of a PSA increase of more than 2 ng/m L regardless of the nadir value [26], and in Canada, it has been recommended to use a combination of testosterone and PSA levels (≤0.7 nmol/L and ≤2 ng/m L, respectively) [27].
JMIR Cancer 2023;9:e44332
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section